Thanks OvF for the detail that you always put in your posts.
My instant reaction to the interesting find by Flotsam was a degree of apprehension but that has now passed and I am left wondering like many what is the point of publishing an old study that shows PG administered by itself in a low dose.
My gut feel is that it may be used by someone somewhere to try to circumvent the strong patent protection that is in place by demonstrating "Prior Art". It is possible that an action like this could create some legal argument, however I don't believe that using PG in a combination of drugs is the same as using it stand alone.
if I was to speculate as to motives of why someone would want to do release this study there are many reasons but my hunch is that it could be that someone is running a ruler over the business and might seek to use this as a means to strengthen their bargaining position. Additionally, you would not go to the effort unless there was a high probability that the treatment as protected by Dimerix patents was working as that would be pointless.
Whatever, someone is spending some money and going to a little trouble and this would be total waste unless it fit into their strategy.
I have no proof of any of my speculating, I might leave it now to others now to think up further possibilities as there could be many more that the HC crowd could forsee.
Good luck all holders,
The Rad
- Forums
- ASX - By Stock
- DXB
- General Discussion
General Discussion, page-45
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
47.5¢ |
Change
-0.015(3.06%) |
Mkt cap ! $261.3M |
Open | High | Low | Value | Volume |
49.5¢ | 49.5¢ | 46.5¢ | $2.742M | 5.746M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 158396 | 47.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
48.0¢ | 162500 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 158396 | 0.475 |
7 | 184132 | 0.470 |
6 | 109327 | 0.465 |
10 | 226428 | 0.460 |
4 | 103472 | 0.455 |
Price($) | Vol. | No. |
---|---|---|
0.480 | 162500 | 2 |
0.485 | 31250 | 1 |
0.490 | 75153 | 3 |
0.495 | 86890 | 6 |
0.500 | 174085 | 5 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online